Explore / Clinical trial
Clinical trial

Psilocybin After Trauma Surgery for Pain

Trent EmerickNot yet recruitingPhase 1Started Dec 31, 202770 enrolledUnited StatesNCT07406828

Abstract

The goal of this clinical trial is to evaluate whether a single dose of psilocybin is feasible and safe for adults with opioid use disorder (OUD) who are recovering from trauma surgery. The main questions it aims to answer are: 1. Is a single psilocybin dose feasible to administer during postoperative hospitalization? 2. Is psilocybin safe in this patient population? 3. How does psilocybin affect postoperative pain, opioid use, anxiety, and depression after hospital discharge? Participants will: Receive one oral dose of psilocybin during their postoperative inpatient stay Complete assessments of pain, mood, and opioid use during recovery

Topics & conditions

Detected automatically by Psychedelic Commons from the title and abstract, not labels from the source. They may be incomplete.

PsilocybinPain

Keywords

postoperative traumaopioidopioid use preventionsurgerymushroomsopioid adverse eventsPain ManagementPostoperative Pain

Psychedelic Commons aggregates metadata from open sources and links back to the original. Rights remain with the authors and publishers. Something wrong with this record? Report a problem.